Human Serum Metabolites Associate With Severity and Patient Outcomes in Traumatic Brain Injury-Reference-Cited by-同舟云学术

Human Serum Metabolites Associate With Severity and Patient Outcomes in Traumatic Brain Injury

Published:2016-10 Issue: Volume:12 Page:118-126
ISSN:2352-3964
Container-title:EBioMedicine
language:en
Short-container-title:EBioMedicine

Author:

Orešič Matej,Posti Jussi P.,Kamstrup-Nielsen Maja H.,Takala Riikka S.K.,Lingsma Hester F.,Mattila Ismo,Jäntti Sirkku,Katila Ari J.,Carpenter Keri L.H.,Ala-Seppälä Henna,Kyllönen Anna,Maanpää Henna-Riikka,Tallus Jussi,Coles Jonathan P.,Heino Iiro,Frantzén Janek,Hutchinson Peter J.,Menon David K.,Tenovuo Olli,Hyötyläinen Tuulia

Funder

EU FP7 project TBIcare

GE-NFL Head Health Challenge I Award

EVO funding

Maire Taponen Foundation

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference45 articles.

1. Predictors of acute child and family outcome following traumatic brain injury in children;Anderson;Pediatr. Neurosurg.,2001

2. Identification of inflicted traumatic brain injury in well-appearing infants using serum and cerebrospinal markers: a possible screening tool;Berger;Pediatrics,2006